fenistil 1 mg/ml oralne kapi, otopina
glaxosmithkline dungarvan ltd., knockbrack, dungarvan, county waterford, irska - dimetindenmaleat - oralne kapi, otopina - 1 mg/ml - urbroj: 1 ml otopine sadrži 1 mg dimetindenmaleata
vepacel
ology bioservices ireland ltd - virusi influence (cijeli virion, inaktivirani), koji sadrže antigen od: a / vietnam / 1203/2004 (h5n1) - influenza, human; immunization; disease outbreaks - cjepiva protiv gripe - aktivna imunizacija protiv h5n1 podtipa virusa influence a. ovaj prikaz se temelji na imunogenosti podataka od ispitanika u dobi od 6 mjeseci i dalje nakon uvođenja dvije doze cjepiva, kuhani s podtipa h5n1 sojeva . vepacel mora se koristiti u skladu sa službenim vodstvom.
zinbryta
biogen idec ltd - declizumaba - multipla skleroza - imunosupresivi - zinbryta je indicirana kod odraslih bolesnika za liječenje relapsnih oblika multiple skleroze (rms).
sitagliptin accord
accord healthcare s.l.u. - sitagliptin hydrochloride - dijabetes mellitus, tip 2 - lijekovi koji se koriste u dijabetesu - for adult patients with type 2 diabetes mellitus, sitagliptin accord is indicated to improve glycaemic control:as monotherapy:- in patients inadequately controlled by diet and exercise alone and for whom metformin is inappropriate due to contraindications or intolerance. as dual oral therapy in combination with:- metformin when diet and exercise plus metformin alone do not provide adequate glycaemic control. - a sulphonylurea when diet and exercise plus maximal tolerated dose of a sulphonylurea alone do not provide adequate glycaemic control and when metformin is inappropriate due to contraindications or intolerance. - a peroxisome proliferator-activated receptor gamma (ppary) agonist (i. a thiazolidinedione) when use of a ppary agonist is appropriate and when diet and exercise plus the ppary agonist alone do not provide adequate glycaemic control. as triple oral therapy in combination with:- a sulphonylurea and metformin when diet and exercise plus dual therapy with these medicinal products do not provide adequate glycaemic control. - a ppary agonist and metformin when use of a ppary agonist is appropriate and when diet and exercise plus dual therapy with these medicinal products do not provide adequate glycaemic control. sitagliptin accord is also indicated as add-on to insulin (with or without metformin) when diet and exercise plus stable dose of insulin do not provide adequate glycaemic control.
utrogestan 200 mg meke kapsule za rodnicu
besins healthcare ireland limited, 16 pembroke street upper, dublin 2, irska - progesteron - kapsula za rodnicu, meka - 200 mg - urbroj: jedna kapsula sadrži 200 mg progesterona (mikroniziranog)
lymphoseek
navidea biopharmaceuticals europe ltd. - tilmanocept - radionuklidno slikanje - otkrivanje tumora, dijagnostičkih радиофармпрепаратов - ovaj je lijek samo za dijagnostičku uporabu. lymphoseek меченных radioaktivnih izotopa je namijenjen za otkrivanje i интраоперационной vizualizacije psi limfnih čvorova, дренирующих primarni tumor kod odraslih pacijenata s rakom dojke, melanomom, ili lokalizirani karcinom pločastih stanica usne šupljine. vanjske vizualizacije i интраоперационной procjene može se izvesti uz pomoć uređaja detekcije gama .
ugljikov dioksid linde, medicinski plin, ukapljen
linde gas hungary co. ltd., carl von linde u. 1, repcelak, mađarska - ugljikov dioksid - medicinski plin, ukapljen - 100% - urbroj: ugljikov dioksid (co2) – 100% (v/v)
hemlibra 30mg/ml rastvor za injekciju
"hoffmann-la roche ltd" d.s.d. podgorica - emicizumab - rastvor za injekciju - 30mg/ml
hemlibra 60mg/0.4ml rastvor za injekciju
"hoffmann-la roche ltd" d.s.d. podgorica - emicizumab - rastvor za injekciju - 60mg/0.4ml
hemlibra 105mg/0.7ml rastvor za injekciju
"hoffmann-la roche ltd" d.s.d. podgorica - emicizumab - rastvor za injekciju - 105mg/0.7ml